SACCHI, Matteo
 Distribuzione geografica
Continente #
SA - Sud America 991
AS - Asia 928
NA - Nord America 799
EU - Europa 219
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.994
Nazione #
BR - Brasile 885
US - Stati Uniti d'America 730
SG - Singapore 416
CN - Cina 121
HK - Hong Kong 116
VN - Vietnam 73
IT - Italia 62
AR - Argentina 36
TR - Turchia 32
GB - Regno Unito 30
IN - India 27
MX - Messico 27
BD - Bangladesh 25
CA - Canada 24
EC - Ecuador 22
IQ - Iraq 21
DE - Germania 18
RU - Federazione Russa 18
ZA - Sudafrica 18
UZ - Uzbekistan 17
CO - Colombia 16
PK - Pakistan 12
ID - Indonesia 11
NL - Olanda 11
PL - Polonia 11
UA - Ucraina 11
VE - Venezuela 11
JP - Giappone 9
KE - Kenya 9
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
FI - Finlandia 8
MA - Marocco 8
SE - Svezia 7
FR - Francia 6
AT - Austria 5
DO - Repubblica Dominicana 5
ES - Italia 5
JO - Giordania 5
PE - Perù 5
PS - Palestinian Territory 5
AL - Albania 4
AZ - Azerbaigian 4
CL - Cile 4
NP - Nepal 4
SA - Arabia Saudita 4
AO - Angola 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
LT - Lituania 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
CG - Congo 2
DK - Danimarca 2
EG - Egitto 2
HN - Honduras 2
KZ - Kazakistan 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
CM - Camerun 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
MD - Moldavia 1
MN - Mongolia 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
TH - Thailandia 1
TN - Tunisia 1
Totale 2.994
Città #
Dallas 404
Singapore 201
Hong Kong 116
Ashburn 68
São Paulo 64
Beijing 54
Los Angeles 35
Rio de Janeiro 32
Ho Chi Minh City 31
Belo Horizonte 26
Shanghai 26
Curitiba 19
New York 19
Brasília 17
Tashkent 15
Johannesburg 14
Istanbul 13
Salvador 13
Santa Clara 13
Hanoi 12
Montreal 11
Porto Alegre 11
Warsaw 11
Denver 10
Brooklyn 9
Guayaquil 9
Orem 9
Ribeirão Preto 9
Amsterdam 8
Betim 8
Nairobi 8
Tokyo 8
Baghdad 7
Chennai 7
London 7
Osasco 7
Atlanta 6
Campinas 6
Chicago 6
Lahore 6
Mexico City 6
New Delhi 6
Poplar 6
Recife 6
São José dos Campos 6
Uberlândia 6
Amman 5
Anápolis 5
Caracas 5
Caxias do Sul 5
Contagem 5
Dubai 5
Duque de Caxias 5
Houston 5
Jacareí 5
Joinville 5
Manaus 5
Manchester 5
Piracicaba 5
Praia Grande 5
Quito 5
Romola 5
Santos 5
Sorocaba 5
Sumaré 5
Várzea Paulista 5
Ankara 4
Aracaju 4
Baku 4
Cotia 4
Council Bluffs 4
Cuiabá 4
Erbil 4
Goiânia 4
Haiphong 4
Imperatriz 4
Itaguaí 4
João Pessoa 4
Juiz de Fora 4
Lima 4
Milan 4
Munich 4
Nuremberg 4
Phoenix 4
Presidente Prudente 4
Ramallah 4
Ribeirão das Neves 4
San Francisco 4
Santo André 4
Sete Lagoas 4
Stockholm 4
Teresina 4
Tianjin 4
Tirana 4
Araraquara 3
Balneário Camboriú 3
Barcarena 3
Belém 3
Bishkek 3
Biên Hòa 3
Totale 1.621
Nome #
In Vitro Activity of a New Ophthalmic Spray Containing Biosecur® Citrus Extract (Oftasecur®) Against Candida auris and Candida albicans and Preformed Biofilm on Contact Lenses 120
Autologous serum eye drops in the management of ocular surface disorders: a systematic review 102
Endothelial Cell Density After XEN Implant Surgery: Short-term Data From the Italian XEN Glaucoma Treatment Registry (XEN-GTR) 84
A machine learning approach to predict the glaucoma filtration surgery outcome 82
Endonasal dacryocystorhinostomy in a pediatric patient with ectrodactyly-ectodermal dysplasia after failure of external dacryocystorhinostomy and as first procedure 80
Autologous serum eye drops in the management of ocular surface disorders: a systematic review 79
The c-jun N-terminal kinase plays a key role in ocular degenerative changes in a mouse model of Alzheimer disease suggesting a correlation between ocular and brain pathologies 77
Efficacy of atropine 0.01% for the treatment of childhood myopia in European patients 76
Conjunctival thickness as a predictive imaging biomarker for the glaucoma filtration surgery outcome: An optical coherence tomography study 76
A latanoprost cationic emulsion (STN1013001) vs. other latanoprost formulations (Latanoprost) in open angle glaucoma/ocular hypertension and ocular surface disease: an Italian cost-utility analysis 76
Intraocular pressure control after combined phacotrabeculectomy versus trabeculectomy alone 76
Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative Glaucoma: A Retrospective European Multicenter Study 73
Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial 72
Corneal involvement in uneventful cataract surgery: an in vivo confocal microscopy study 69
Effectiveness and safety of XEN45 implant over 12 months of follow-up: data from the XEN-Glaucoma Treatment Registry 68
Efficacy of Bimatoprost Plus Timolol Fixed Combination in Open Angle Glaucoma Patients Previously Treated with Dorzolamide Plus Timolol Fixed Combination 67
Efficacy and Safety of XEN63 Gel Stent Implant over 6 Months for Treatment of Glaucoma 67
Impact of Adherence (Compliance) to Oral Acyclovir Prophylaxis in the Recurrence of Herpetic Keratitis: Long-Term Results From a Pediatric Cohort 66
A deep learning approach to investigate the filtration bleb functionality after glaucoma surgery: a preliminary study 65
The effects of topical coenzyme Q10 and vitamin E D-α-tocopheryl polyethylene glycol 1000 succinate after cataract surgery: a clinical and in vivo confocal study 64
Sutureless "Contact Lens Sandwich" Technique for Amniotic Membrane Therapy of Central Corneal Ulcers 62
Posner-Schlossman Syndrome European Study Group: study protocol and baseline patients characteristics of a multicentre study 62
Retractor plication versus retractor plication and lateral tarsal strip for eyelid entropion correction 61
Efficacy of preservative-free tafluprost in patients with normal-tension glaucoma previously treated with latanoprost 61
Spectral-domain optical coherence tomography measurements of central foveal thickness before and after cataract surgery in children 61
Citicoline/Coenzyme Q10/Vitamin B3 Fixed Combination Exerts Synergistic Protective Effects on Neuronal Cells Exposed to Oxidative Stress 60
Neuroprotection beyond intraocular pressure: game changer or quiet addiction 59
In Vivo Optical Coherence Tomography Outcomes of Hypotony After Trabeculectomy Management with Autologous Blood Injection: A Single-Center Retrospective Study 57
Pediatric Conjunctivitis and Air Pollution Exposure: A Prospective Observational Study 57
A prospective study evaluating IOP changes after switching from a therapy with prostaglandin eye drops containing preservatives to nonpreserved tafluprost in glaucoma patients 57
Hallermann-Streiff syndrome with severe bilateral enophthalmos and radiological evidence of silent brain syndrome: a new congenital silent brain syndrome? 56
Efficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literature 54
Medical management of pediatric glaucoma: lessons learned from randomized clinical trials 53
Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy 53
Treatment of open-angle glaucoma and ocular hypertension with preservative-free tafluprost/timolol fixed-dose combination therapy: 6 case reports and clinical outcomes 48
The Ocular Surface Frailty Index as a Predictor of Ocular Surface Symptom Onset after Cataract Surgery 48
The Ocular Surface in Medically Controlled Glaucoma: An In Vivo Confocal Study 48
Structural imaging of conjunctival filtering blebs in XEN gel implantation and trabeculectomy: a confocal and anterior segment optical coherence tomography study 46
Evaluation of levator function for efficacy of minimally invasive and standard techniques for involutional ptosis 44
Risk Factors for Failure in Glaucoma Patients Undergoing Microshunt Implantation 41
Prevalence of SARS-CoV-2 amongst ophthalmologists throughout the first and second waves of the pandemic 40
The ocular surface after successful glaucoma filtration surgery: a clinical, in vivo confocal microscopy, and immune-cytology study 39
Risk Factors for Failure in Glaucoma Patients Undergoing Microshunt Implantation 38
Effectiveness and Safety of XEN45 in Eyes With High Myopia and Open Angle Glaucoma 37
Response to "Letter to the Editor relating to Graefe's Arch Clin Exp Ophthalmol. 2020 June. 'Medical management of pediatric glaucoma: lessons learned from randomized clinical trials'" 37
Ocular surface and glaucoma, a mutual relationship. Practical suggestions for classification and management 36
Safety and Efficacy of Ab Interno XEN 45 Gel Stent in Patients with Glaucoma and High Myopia 35
Preparing the ocular surface for glaucoma filtration surgery: an unmet clinical need 34
Genetic evaluation in phenotypically discordant monozygotic twins with Coats Disease 32
Managing the ocular surface after glaucoma filtration surgery: an orphan topic 31
Italian Candidates for the XEN Implant: An Overview from the Glaucoma Treatment Registry (XEN-GTR) 20
Italian XEN-Glaucoma Treatment Registry (XEN-GTR): Effectiveness and Safety at 36 Months of XEN45 Implant 14
Recurrence-free time after pterygium surgery with sutureless conjunctival-limbal vs. conjunctival graft: is there still a role for conjunctival graft alone? 14
In vitro antibacterial efficacy and antibiofilm activity on contact lenses of a new ophthalmic spray containing Biosecur® citrus extract (Oftasecur®) 12
Italian glaucoma virtual clinics: Developing a consensus for remote patient management 8
“Intrableb pigmentation following XEN implantation: A case series” 8
Totale 3.062
Categoria #
all - tutte 11.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.304


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024107 0 0 0 0 0 0 0 0 0 66 7 34
2024/20251.569 3 1 67 24 34 48 125 416 489 259 73 30
2025/20261.386 105 419 198 408 228 28 0 0 0 0 0 0
Totale 3.062